Meet Dr. Salas-Whalen

Dr. Salas-Whalen’s passion for medicine and her patients’ wellness fuels THE results-driven approach to her practice

 
 

Dr. Salas-Whalen is a board-certified physician specializing in Obesity Medicine and Endocrinology. She is a trailblazer in the fields of obesity and peri and menopause management, recognized for her expertise in integrating groundbreaking treatments like GLP-1 medications into personalized care plans. As one of the earliest adopters of these transformative therapies, she has helped redefine the approach to weight management, providing sustainable solutions to a historically misunderstood condition.

Her work extends beyond weight management to include a passionate focus on perimenopause and menopause. Dr. Salas-Whalen is at the forefront of what she calls a "menopause redo," where modern science and tailored care empower women to embrace this life stage with strength and vitality. Combining hormonal expertise with a deep understanding of midlife health, she helps patients navigate complex transitions confidently and clearly.

In addition to clinical practice, Dr. Salas-Whalen has a very strong social media presence, including her Instagram @drsalaswhalen, where she educates, inspires, and empowers individuals to take charge of their health.

Dr. Salas-Whalen is writing a comprehensive guide on obesity and GLP-1 medications and is the founder of @StrengthMD and @thedryrevolution, initiatives to promote wellness and empower individuals to take control of their health journeys.

An immigrant from Mexico who realized her dream of becoming a physician after moving to the United States, Dr. Salas-Whalen now leads a thriving practice in New York City. Her innovative, science-based approach has made her a trusted authority in redefining care for women and those living with obesity.

Dr. Salas-Whalen’s mission is clear: to transform lives by addressing the root causes of health challenges with empathy, cutting-edge science, and unwavering dedication.

 
 
 

Why choose Dr. Salas-Whalen?

Dr. Salas-Whalen will provide you with caring, highly personalized care that begins with taking the time to fully understand your needs. Her primary objective is to provide you with greater knowledge and, as a result, more control of your health.

For additional information, follow Dr. Salas-whalen:

BOARD CERTIFICATIONS:

  • Obesity Medicine


EDUCATION AND TRAINING:

  • Fellowship in Endocrinology, Diabetes and Metabolism at University of Maryland

  • Research fellow in Obesity Surgery at John Hopkins University

  • Residency in Internal Medicine at Jacobi Medical Center as part of Albert Einstein School of Medicine in New York

  • Universidad Autonoma de Ciudad Juarez, Chihuahua Mexico

 
 

publications

 

“Pancreatic Polypeptide Administration Enhances Insulin Sensitivity and Reduces the Insulin Requirement of Patients on Insulin Pump Therapy” (manuscript submission). A. Rabiee, P. Galiatsatos, R. Salas-Carrillo, M.D. Thompson, D.K. Andersen and D. Elahi. Journal of Clinical Endocrinology and Metabolisim (2011). Departments of Surgery and Medicine, Johns Hopkins - Bayview Medical Center, Baltimore, MD and Department of Medicine, University of Massachusetts MedicalSchool, Worcester, MA.
READ HERE →

“Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric bypass: Unraveling the Role of Gut Hormone and Pancreatic Endocrine Dysfunction.” A. Rabiee, J.T. Magruder, R. Salas-Carrillo, J.M. Egan, D. Elahi and D.K.Andersen. Journal of Surgical Research (2010): 1-7. Department of Surgery, Medicine and Pathology,Johns Hopkins University School of Medicine - Bayview Medical Center, Baltimore, MD.
READ HERE →

“Nesidioblastosis in a Patient with HIV and History of Opiod Use” (abstract, presentation). R. Salas-Carillo, H.R. Alexander and E. Streeten. 91stAnnual Meeting of the Endocrine Society (2009). Division of Endocrinology, Diabetes and Nutrition and Division of Surgical Oncology, University of Maryland, Baltimore, MD.

Disparate Improvement in Peripheral Tissue Sensitivity and Hepatic Tissue Insulin Sensitivity Following Bariatric Surgery” (abstract, presentation). A. Rabiee, P. Galiatsatos, R. Salas-Carillo, A.O. Lidor, K.E. Steele, M.D. Schweitzer, T.H. Magnuson, M. Habibi, B.R. Gibson, D.K. Andersen and D. Elahi. 92nd Annual Meeting of the Endocrine Society (2010). Department of Surgery, Medicine and Pathology, Johns Hopkins University School of Medicine - Bayview Medical Center, Baltimore,MD.
READ HERE →

“Accuracy and reliability of the Nova Stat-Strip Glucose Meter for Real-Time Blood Glucose Determinations During Glucose Clamp Studies.” A. Rabiee, T. Magruder, C. Grant, R. Salas-Carrillo, A. Gillette, J. DuBois, R. Shannon, D.K. Andersen and D. Elahi. Journal of Diabetes Science and Technology 4.5 (2010): 1195-1201. Department of Surgery, Medicine and Pathology, Johns Hopkins University School of Medicine - Bayview Medical Center, Baltimore, MD, Nova Biomedical,Waltham, MA and Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA.
READ HERE →

“Prospective Study of Gut Hormone and Metabolic Changes after Adjustable Gastric Banding and Roux-en-Y Gastric Bypass.” J. Korner, W. Inabnet, G. Febres, I.M. Conwell, D.J. McMahon, R. Salas-Carrillo, C. Taveras, B. Schrope and M. Bessler. International Journal of Obesity (2009): 1-10. Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA and Department of Surgery, Columbia University College of Physicians and Surgeons,New York, NY.
READ HERE →